Clinical responses and lymphoid infiltrates in metastatic melanoma following treatment with intralesional GM-CSF

Melanoma Research

Volumn 6, Issue 3, 1996, Pages 247-255

  Si, Z ^a   Hersey, P ^a   Coates, A S ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Intralesional GM CSF; Melanoma; Subcutaneous metastases; T cell infiltrates

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; INTRALESIONAL DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; SKIN NEOPLASMS; T-LYMPHOCYTE SUBSETS;

EID: 0029949031     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199606000-00008     Document Type: Article

References (29)

1. Metcalf D. Control of granulocytcs and macrophages: molecular, cellular and clinical aspects. Science 1991; 254: 529-533.
2. Groopman JE, Molina J-M, Scadden DT. Hematopoietic growth factors. Biology and clinical applications. N Engl J Med 1989; 321: 1449-1459.
3. Coleman DL, Chodakewitz JA, Bartiss AH, et al. Granulocyte-macrophage colony-stimulating factor enhances selective effector functions of tissue-derived macrophages. Blood 1988; 72: 573-578.
4. Grabstein KH, Urdai DL, Tushinski RJ, et al. Induction of macrophage tumouricidal activity by granulocyte-macrophage colony-stimulating factor. Science 1986; 232: 506-508.
5. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 1992; 327: 99-106.
6. Nemunaitis J, Rabinowe SN, Singer JW, et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 1991; 324: 1773-1778.
7. Witmer-Pack MD, Olivier W, Valinsky J, et al. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans' cells. J Exp Med 1987; 166: 1484-1498.
8. Heufler C, Koch F, Schuler, G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans' cells into potent immunostimulatory dendritic cells. J Exp Med 1988; 167: 700-705.
9. Morrissey PJ, Bressler L, Park LS, et al. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J Immunol 1987; 139: 1113-1119.
10. Silberberg-Sinakin I, Gigli I, Baer RL, et al. Langerhans' cells: role in contact hypersensitivity and relationship to lymphoid dendritic cells and to macrophages. Immunol Rev 1980; 53: 203-232.
11. Romani N, Schuler G, Fritsch P. Identification and phenotype of epidermal Langerhans' cells. In: Schuler G, eds. Epidermal Langerhans' Cells. Boca Raton: CRC Press, 1991: 49-84.
12. Streilein JW, Grammer SF, Yoshikawa T, et al. Functional dichotomy between Langerhans' cells that present antigen to naive and to memory/effector T lymphocytes. Immunol Rev 1990; 117: 159-183.
13. Kaplan G, Walsh G, Guido LS, et al. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony stimulating factor: Langerhans' cell recruitment, keratinocyte growth, and enhance wound healing. J Exp Med 1992; 175: 1717-1728.
14. Kurimoto I, Streilein JW. Cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumour necrosis factor-alpha. J Immunol 1992; 148: 3072-3078.
15. Caux C, Dezutter-Dambuyant C, Schmitt D, et al. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans' cells. Nature 1992; 360: 258-261.
16. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180: 83-93.
17. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumour cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumour immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
18. Golumbek PT, Azhari R, Jaffee EM, et al. Controlled release, biodegradable cytokine depots: A new approach in cancer vaccine design. Cancer Res 1993; 53: 5841-5844.
19. Huang AYC, Golumbek P, Ahmadzadeh M, et al. Role of bone marrow- derived cells in presenting MHC class I-restricted tumour antigens. Science 1994; 264: 961-965.
20. Miller AB, Hoogstraaten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
21. Si Z, Hersey P. Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer 1993; 54: 37-43.
22. Brooks DA, Zola H, McNamara PJ, et al. Membrane antigens of human cells of the monocyte/macrophage lineage studied with monoclonal antibodies. Pathology 1983; 15: 45-52.
23. Bradstock K, Hewson J, Kerr A, et al. Expression of terminal deoxynucleotidyl transferase in myeloblasts. Am J Clin Pathol 1983; 80: 800-805.
24. Bumol TF, Reisfeld RA. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sci USA 1982; 79: 1245-1249.
25. Vennegoor C, Calafat J, Hageman P, et al. Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3. Int J Cancer 1985; 35: 287-295.
26. Hart DN, Starling GC, Calder VL, et al. B7/BB-1 is a leukocyte differentiation antigen on human dendritic cells induced by activation. Immunology 1993; 79: 616-620.
27. Alderson MR, Armitage RJ, Tough TW, et al. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993; 178: 669-674.
28. Hersey P, Si Z, Smith MJ, Thomas WD. Expression of the co-stimulatory molecule B7 on melanoma cells. Int J Cancer 1994; 58: 527-532.
29. Chen Q, Daniel V, Maher DW, Hersey P. Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int J Cancer 1994; 56: 755-760.